Evoke Pharma Stock Alpha and Beta Analysis
| EVOK Stock | USD 4.35 0.02 0.46% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Evoke Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Evoke Pharma over a specified time horizon. Remember, high Evoke Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Evoke Pharma's market risk premium analysis include:
Beta 1.26 | Alpha (0) | Risk 6.35 | Sharpe Ratio 0.026 | Expected Return 0.17 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Evoke |
Evoke Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Evoke Pharma market risk premium is the additional return an investor will receive from holding Evoke Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Evoke Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Evoke Pharma's performance over market.| α | -0.0016 | β | 1.26 |
Evoke Pharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Evoke Pharma's Buy-and-hold return. Our buy-and-hold chart shows how Evoke Pharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Evoke Pharma Market Price Analysis
Market price analysis indicators help investors to evaluate how Evoke Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evoke Pharma shares will generate the highest return on investment. By understating and applying Evoke Pharma stock market price indicators, traders can identify Evoke Pharma position entry and exit signals to maximize returns.
Evoke Pharma Return and Market Media
The median price of Evoke Pharma for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 4.95 with a coefficient of variation of 13.53. The daily time series for the period is distributed with a sample standard deviation of 0.67, arithmetic mean of 4.92, and mean deviation of 0.55. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 375 shares by Donofrio Matthew J of Evoke Pharma at 0.62 subject to Rule 16b-3 | 09/06/2024 |
2 | Acquisition by Marilyn Carlson of 75000 shares of Evoke Pharma at 0.62 subject to Rule 16b-3 | 09/12/2024 |
3 | Evoke Pharma Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments | 09/19/2024 |
4 | Acquisition by Garner Cam L of 67500 shares of Evoke Pharma at 0.66 subject to Rule 16b-3 | 09/26/2024 |
5 | Acquisition by Donofrio Matthew J of 150000 shares of Evoke Pharma at 2.94 subject to Rule 16b-3 | 10/07/2024 |
6 | Disposition of 40357 shares by Donofrio Matthew J of Evoke Pharma at 2.91 subject to Rule 16b-3 | 10/11/2024 |
7 | Insider Trading | 10/18/2024 |
8 | Evoke Pharma Gains Momentum with GIMOTI Study Success | 10/28/2024 |
9 | What Financial Challenges Does Evoke Pharma Face | 10/29/2024 |
10 | Evoke Pharma earnings missed by 0.95, revenue fell short of estimates | 11/08/2024 |
11 | Evoke Pharma Now Covered by StockNews.com | 11/14/2024 |
About Evoke Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Evoke or other stocks. Alpha measures the amount that position in Evoke Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 0.38 | 0.43 | 0.12 | 0.2 | Days Of Inventory On Hand | 206.39 | 285.16 | 871.17 | 648.49 |
Evoke Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Evoke Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Evoke Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Evoke Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Evoke Pharma. Please utilize our Beneish M Score to check the likelihood of Evoke Pharma's management manipulating its earnings.
| 19th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Evoke Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Evoke Pharma Backtesting, Evoke Pharma Valuation, Evoke Pharma Correlation, Evoke Pharma Hype Analysis, Evoke Pharma Volatility, Evoke Pharma History and analyze Evoke Pharma Performance. For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Evoke Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.